Celltrion
068270 · KRX · Health Care · Biotechnology and Biosimilars
Tentang perusahaan
Celltrion is a South Korean biopharmaceutical company that develops, manufactures, and commercializes biosimilar medicines targeting major autoimmune and oncology conditions. It is one of the largest biosimilar producers globally and sells its products in the United States, Europe, and Asia through its commercialization subsidiary Celltrion Healthcare. The company operates large-scale mammalian cell culture manufacturing facilities in Incheon.
| Bursa | KRX |
| Kode saham | 068270 |
| Sektor | Health Care · Biotechnology and Biosimilars |
| Kapitalisasi pasar indikatif USD | $38.00B |
| Situs web | Kunjungi situs web |
Harga langsung
Memuat harga terkini…
| Kapitalisasi pasar | |
| Kisaran harian | |
| Kisaran 52 minggu |
Cara membeli
Di pasar asal (KRX), dapat diakses melalui broker global yang menawarkan bursa tersebut:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Korea Exchange, which operates the KOSPI Market for large-cap equities, the KOSDAQ Market for growth and technology companies, and a Derivatives Market division. — pencatatan resmi di bursa
Hanya informasi ketersediaan, bukan rekomendasi atau penawaran untuk membeli. Konfirmasikan kelayakan, biaya, dan ketersediaan terkini dengan broker Anda.
Perusahaan lain di South Korea
Data perusahaan dan harga langsung apa pun bersifat indikatif, mungkin tertunda atau tidak akurat, dan hanya untuk riset, bukan saran investasi. Verifikasi dengan bursa, pengajuan perusahaan, dan broker Anda.